• We reviewed the treatment outcome in 40 patients undergoing full-thickness local excision (seven patients) or electrocoagulation (33 patients) for adenocarcinoma of the rectum. Patients were followed up for a minimum of 5 years or until death (mean follow-up, 7.6 years). Twenty-two patients (55%) survived 5 years free of disease or were free of disease at the time of death due to other causes following local treatment. Eight (62%) of 13 patients with persistent or locally recurrent disease were successfully treated with additional local therapy, rectal resection, or combined radiation therapy and chemotherapy. Overall, 30(75%) of 40 patients embarking on a program of local treatment for carcinoma of the rectum survived 5 years free of disease or were free of disease at the time of death due to other causes.
(Arch Surg. 1993;128:545-550)
Stahl TJ, Murray JJ, Coller JA, Schoetz DJ, Roberts PL, Veidenheimer MC. Sphincter-Saving Alternatives in the Management of Adenocarcinoma Involving the Distal Rectum: 5-Year Follow-up Results in 40 Patients. Arch Surg. 1993;128(5):545–550. doi:10.1001/archsurg.1993.01420170079011
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.